Short and long interval cortical inhibition in patients with Unverricht-Lundborg and Lafora body disease

Epilepsy Research

Volumn 89, Issue 2-3, 2010, Pages 232-237

  Canafoglia, Laura ^a   Ciano, Claudia ^a   Visani, Elisa ^a   Anversa, Paola ^a   Panzica, Ferruccio ^a   Viri, Maurizio ^b   Gennaro, Elena ^c   Zara, Federico ^d   Madia, Francesca ^c   Franceschetti, Silvana ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b FATEBENEFRATELLI HOSPITAL   (Italy)

^c Laboratory of Human Genetics   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Lafora body disease; Paired pulse protocols; Progressive myoclonus epilepsy; Transcranial magnetic stimulation; Unverricht Lundborg disease

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CYSTATIN B; ETIRACETAM; LAMOTRIGINE; PHENOBARBITAL; PIRACETAM; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EPILEPTOGENESIS; EXCITATORY POSTSYNAPTIC POTENTIAL; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; INTERNEURON; MALE; MOTOR CORTEX; MYOCLONUS; MYOCLONUS EPILEPSY; NERVE CELL NETWORK; NEUROPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; AGED; CEREBRAL CORTEX; FEMALE; HUMANS; LAFORA DISEASE; MALE; MIDDLE AGED; NERVE NET; NEURAL INHIBITION; REACTION TIME; TIME FACTORS; TRANSCRANIAL MAGNETIC STIMULATION; UNVERRICHT-LUNDBORG SYNDROME;

EID: 77951295967     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2010.01.006     Document Type: Article

References (40)

1. Airaksinen E.M., Leino E. Decrease of GABA in the cerebrospinal fluid of patients with progressive myoclonus epilepsy and its correlation with the decrease of 5HIAA and HVA. Acta Neurol. Scand. 1982, 66:666-672.
2. Badawy R.A., Curatolo J.M., Newton M., Berkovic S.F., Macdonell R.A. Changes in cortical excitability differentiate generalized and focal epilepsy. Ann. Neurol. 2007, 61:324-331.
3. Brown P., Ridding M.C., Werhahn K.J., Rothwell J.C., Marsden C.D. Abnormalities of the balance between inhibition and excitation in the motor cortex of patients with cortical myoclonus. Brain 1996, 119:309-317.
4. Canafoglia L., Ciano C., Panzica F., Scaioli V., Zucca C., Agazzi P., Visani E., Avanzini G., Franceschetti S. Sensorimotor cortex excitability in Unverricht-Lundborg disease and Lafora body disease. Neurology 2004, 63:2309-2315.
5. Caramia M.D., Gigli G., Iani C., Desiato M.T., Diomedi M., Palmieri M.G., Bernardi G. Distinguishing forms of generalized epilepsy using magnetic brain stimulation. Electroencephalogr. Clin. Neurophysiol. 1996, 98:14-19.
6. Chan E.M., Ackerley C.A., Lohi H., Ianzano L., Cortez M.A., Shannon P., Scherer S.W., Minassian B.A. Laforin preferentially binds the neurotoxic starch-like polyglucosans, which form in its absence in progressive myoclonus epilepsy. Hum. Mol. Genet. 2004, 13:1117-1129.
7. Chen R. Interactions between inhibitory and excitatory circuits in the human motor cortex. Exp. Brain Res. 2004, 154:1-10.
8. Chew N.K., Mir P., Edwards M.J., Cordivari C., Martino D., Schneider S.A., Kim H.T., Quinn N.P., Bhatia K.P. The natural history of Unverricht-Lundborg disease: a report of eight genetically proven cases. Mov. Disord. 2008, 23:107-113.
9. Danner N., Julkunen P., Khyuppenen J., Hukkanen T., Könönen M., Säisänen L., Koskenkorva P., Vanninen R., Lehesjoki A.E., Kälviäinen R., Mervaala E. Altered cortical inhibition in Unverricht-Lundborg type progressive myoclonus epilepsy (EPM1). Epilepsy Res. 2009, 85:81-88.
10. Destexhe A., Paré D. Impact of network activity on the integrative properties of neocortical pyramidal neurons in vivo. J. Neurophysiol. 1999, 81:1531-1547.
11. Franceschetti S., Sancini G., Buzzi A., Zucchini S., Paradiso B., Magnaghi G., Frassoni C., Chikhladze M., Avanzini G., Simonato M. A pathogenetic hypothesis of Unverricht-Lundborg disease onset and progression. Neurobiol. Dis. 2007, 25:675-685.
12. Genton P. Lafora's disease (EPM2). Rev. Neurol. (Paris) 2007, 163:47-53.
13. Guerrini R., Bonanni P., Parmeggiani L., Hallett M., Oguni H. Pathophysiology of myoclonic epilepsies. Adv. Neurol. 2005, 95:23-46.
14. Hanajima R., Ugawa Y., Terao Y., Ogata K., Kanazawa I. Ipsilateral cortico-cortical inhibition of the motor cortex in various neurological disorders. J. Neurol. Sci. 1996, 140:109-116.
15. Hanajima R., Okabe S., Terao Y., Furubayashi T., Arai N., Inomata-Terada S., Hamada M., Yugeta A., Ugawa Y. Difference in intracortical inhibition of the motor cortex between cortical myoclonus and focal hand dystonia. Clin. Neurophysiol. 2008, 119:1400-1407.
16. Kossev A.R., Schrader C., Däuper J., Dengler R., Rollnik J.D. Increased intracortical inhibition in middle-aged humans; a study using paired-pulse transcranial magnetic stimulation. Neurosci. Lett. 2002, 333:83-86.
17. Kujirai T., Caramia M.D., Rothwell J.C., Day B.L., Thompson P.D., Ferbert A., Wroe S., Asselman P., Marsden C.D. Corticocortical inhibition in human motor cortex. J. Physiol. 1993, 471:501-519.
18. Lefaucheur J.P. Myoclonus and transcranial magnetic stimulation. Neurophysiol. Clin. 2006, 36:293-297.
19. Lalioti M.D., Scott H.S., Buresi C., Rossier C., Bottani A., Morris M.A., Malafosse A., Antonarakis S.E. Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy. Nature 1997, 386:846-851.
20. Li J.Y., Cunic D.I., Paradiso G., Gunraj C., Pal P.K., Lang A.E., Chen R. Electrophysiological features of myoclonus-dystonia. Mov. Disord. 2008, 23:2055-2061.
21. Magaudda A., Gelisse P., Genton P. Antimyoclonic effect of levetiracetam in 13 patients with Unverricht-Lundborg disease: clinical observations. Epilepsia 2004, 45:678-681.
22. Manganotti P., Bongiovanni L.G., Zanette G., Fiaschi A. Early and late intracortical inhibition in juvenile myoclonic epilepsy. Epilepsia 2000, 41:1129-1138.
23. Manganotti P., Tamburin S., Zanette G., Fiaschi A. Hyperexcitable cortical responses in progressive myoclonic epilepsy: a TMS study. Neurology 2001, 57:1793-1799.
24. Marelli C., Canafoglia L., Zibordi F., Ciano C., Visani E., Zorzi G., Garavaglia B., Barzaghi C., Albanese A., Soliveri P., Leone M., Panzica F., Scaioli V., Pincherle A., Nardocci N., Franceschetti S. A neurophysiological study of myoclonus in patients with DYT11 myoclonus-dystonia syndrome. Mov. Disord. 2008, 23:2041-2048.
25. Marseille Consensus Group Classification of progressive myoclonus epilepsies and related disorders. Ann. Neurol. 1990, 28:113-116.
26. Matsumoto R.R., Truong D.D., Nguyen K.D., Dang A.T., Hoang T.T., Vo P.Q., Sandroni P. Involvement of GABA(A) receptors in myoclonus. Mov. Disord. 2000, 15(Suppl. 1):47-52.
27. Meunier S., Lourenco G., Roze E., Apartis E., Trocello J.M., Vidailhet M. Cortical excitability in DYT-11 positive myoclonus dystonia. Mov. Disord. 2008, 23:761-764.
28. Nakamura H., Kitagawa H., Kawaguchi Y., Tsuji H. Intracortical facilitation and inhibition after transcranial magnetic stimulation in conscious humans. J. Physiol. 1997, 498:817-823.
29. Panzica F., Rubboli G., Franceschetti S., Avanzini G., Meletti S., Pozzi A., Tassinari C.A. Cortical myoclonus in Janz syndrome. Clin. Neurophysiol. 2001, 112:1803-1809.
30. Panzica F., Canafoglia L., Franceschetti S., Binelli S., Ciano C., Visani E., Avanzini G. Movement-activated myoclonus in genetically defined progressive myoclonic epilepsies: EEG-EMG relationship estimated using autoregressive models. Clin. Neurophysiol. 2003, 114:1041-1052.
31. Prince D.A., Wilder B.J. Control mechanisms in cortical epileptogenic foci. " Surround" inhibition. Arch. Neurol. 1967, 16:194-202.
32. Rossini P.M., Barker A.T., Berardelli A., Caramia M.D., Caruso G., Cracco R.Q., Dimitrijević M.R., Hallett M., Katayama Y., Lücking C.H., et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr. Clin. Neurophysiol. 1994, 91:79-92.
33. Shibasaki H. AAEE Minimograph #30: electrophysiologic studies of myoclonus. Muscle Nerve 1988, 11:899-907.
34. Smith A.E., Ridding M.C., Higgins R.D., Wittert G.A., Pitcher J.B. Age-related changes in short-latency motor cortex inhibition. Exp. Brain Res. 2009, 198:489-500.
35. Vals-Sole J., Pascual-Leone A., Wassermann E.M., Hallett M. Human motor evoked responses to paired transcranial magnetic stimuli. Electroencephalogr. Clin. Neurophysiol. 1992, 85:355-364.
36. Valzania F., Strafella A.P., Tropeani A., Rubboli G., Nassetti S.A., Tassinari C.A. Facilitation of rhythmic events in progressive myoclonus epilepsy: a transcranial magnetic stimulation study. Clin. Neurophysiol. 1999, 110:152-157.
37. van der Salm S.M., van Rootselaar A.F., Foncke E.M., Koelman J.H., Bour L.J., Bhatia K.P., Rothwell J.C., Tijssen M.A. Normal cortical excitability in myoclonus dystonia-a TMS study. Exp. Neurol. 2009, 216:300-305.
38. Wassermann E.M. Variation in the response to transcranial magnetic brain stimulation in the general population. Clin. Neurophysiol. 2002, 113:1165-1171.
39. Werhahn K.J., Lieber J., Classen J., Noachtar S. Motor cortex excitability in patients with focal epilepsy. Epilepsy Res. 2000, 41:179-189.
40. Ziemann U. TMS and drugs. Clin. Neurophysiol. 2004, 115:1717-1729.